Results 111 to 120 of about 3,153 (174)

SARS-CoV-2: una nueva amenaza. [PDF]

open access: yesAdv Lab Med, 2020
López Rodríguez CA   +5 more
europepmc   +1 more source

[SARS-CoV-2 (COVID-19) in Patients with some Degree of Immunosuppression]. [PDF]

open access: yesReumatol Clin, 2021
Cajamarca-Baron J   +8 more
europepmc   +1 more source

Kinetics of cellular immune response to SARS-CoV-2 vaccine boosters in dialysis and kidney transplant patients without infection. [PDF]

open access: yesJ Bras Nefrol
Souza RM   +5 more
europepmc   +1 more source

Producción de una forma enzimática activa e inmunogénica del ectodominio de la hemaglutinina neuraminidasa (eHN) del Rubulavirus porcino en la levadura Pichia pastoris

open access: yes, 2016
"Debido a las pérdidas económicas ocasionadas por la enfermedad del ojo azul de los cerdos en la industria pecuaria en México, existe la necesidad de generar nuevas herramientas que permitan obtener opciones preventivas de bajo costo, seguras y adaptables a las variantes antigénicas del PorPV.
openaire   +3 more sources

Antibodies to Influenza A Viruses in Wintering Snow Geese (Chen caerulescens) in Texas. [PDF]

open access: yesAvian Dis, 2016
Wong JK   +4 more
europepmc   +1 more source

[Respiratory viriasis. Influenza]. [PDF]

open access: yesMedicine (Baltimore), 2014
Martín Quirós A   +2 more
europepmc   +1 more source

[Microbiological diagnosis of viral respiratory infections]. [PDF]

open access: yesEnferm Infecc Microbiol Clin, 2009
Eiros JM   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy